Aggregator
Unintended consequences of Trump's tariff strategy
Harvard Professor Reza Satchu Breaks Down the Skills Necessary for Thriving Entrepreneurship
At Last, I Have a Positive Net Worth. Now I Just Can’t Let It Go to My Head.
Wall Street Week: Capitalism 4.0
You’re Probably A/B Testing Too Much. Here’s What to Do Instead.
How VCs Make Sure Their Startups See and Be Seen
Why Boldness Can Be A Leader’s Most Critical Attribute
Marketing at the Speed of Culture
Forever Layoffs' Are Everywhere Now — And We Should All Be Terrified
The Top 10 Reasons New Businesses Fail
From Boeing to Financial Times: Real-World Lessons in Trust Leadership
Harvard MBA Grads Are Landing Jobs Paying $184K—but a Record Number Are Still Ditching the Corporate World and Choosing Entrepreneurship Instead
The End of the Lunch Bowl Era
Could Your Company Benefit from Fastvertising?
What a Future Moon Economy Could Look Like
Enhancing Mental Health with Generative Artificial Intelligence: The Promise and the Risks
Gordon Freeman, Arlene Sharpe Receive Inaugural Gretener-Thürlemann Prize
Gordon Freeman , Harvard Medical School professor of medicine at Dana-Farber Cancer Institute, and Arlene Sharpe , the Kolokotrones University Professor and chair of the Department of Immunology in the Blavatnik Institute at HMS, have been awarded the inaugural Gretener-Thürlemann Prize by the University of Zurich. The prize, worth 500,000 Swiss francs or approximately $625,000, recognizes outstanding researchers in medicine, chemistry and physics for foundational and pioneering research of societal benefit. Get more HMS news here Freeman and Sharpe were honored for decades of discoveries that…
Apollo Global Management’s Business Model Transformation
New Faculty Profiles: Quan Le
HBS faculty comprises scholars and practitioners who bring leading-edge research, extensive experience, and deep insights into the classroom, to organizations, and to leaders across the globe. We asked new faculty at HBS about their background, their new roles, and their interests.